Statin effects on the incidence of major non-cardiovascular disease events among a global cohort of people with HIV: a randomised controlled trialMarissa R Diggs, Steven Grinspoon, Triin Umbleja et al.|The Lancet HIV|2025Cited by 3
Risks for sudden cardiac and undetermined cause of death among people with HIV in the REPRIEVE primary cardiovascular prevention trialChristopher R. deFilippi, Steve Grinspoon, Rodger D. MacArthur et al.|AIDS|2025Cited by 3
Heart Failure Risk and Events in People With HIV: The Randomized Trial to Prevent Vascular Events in HIV (REPRIEVE)Gerald S. Bloomfield, Pamela S. Douglas, Maya Watanabe et al.|Circulation Heart Failure|2025Cited by 2
RISKS FOR SUDDEN CARDIAC (SCD) AND UNDETERMINED CAUSE OF DEATH (UDD) AMONG PEOPLE WITH HIV (PWH) IN THE REPRIEVE PRIMARY CARDIOVASCULAR PREVENTION TRIALAya Awwad, Steven Grinspoon, Christopher R. deFilippi et al.|Journal of the American College of Cardiology|2025Cited by 0
Baseline ECG and Cardiovascular Outcomes in People With HIV: Insights From REPRIEVEAya Awwad, Gerald S. Bloomfield, Christopher R. deFilippi et al.|Journal of the American Heart Association|2025Cited by 0